Go to top of page

User guide on active ingredient prescribing

Legislation on active ingredient prescribing was introduced by the Australian Government Department of Health in October 2019 to increase consumers’ understanding of their own medicines, and increase the uptake of generic and biosimilar medicines. In 2019–20, the Commission developed a user guide for prescribers that includes principles for when to specify a brand name in addition to the active ingredient.